Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1639198880
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3401 N Broad St
Philadelphia, PA, 19140
Phone (215) 707-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
336 services
Medicare patients, 2024
85
Average age 73
Drug cost, 2024
$4.4M
1,660 prescriptions
Company payments, 2025
$190
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alvaro Pereira-Rico was code 99214 (office e&m - established), 162 times for 59 patients. In total Alvaro Pereira-Rico billed 336 services in 13 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 162 | 59 | $72.13 | $12K |
| 99215 Office E&M - Established | Facility | 51 | 27 | $110.69 | $5,645 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 49 | 35 | $13.37 | $655 |
By year: 2022 $29K for 316 services; 2023 $31K for 349 services; 2024 $25K for 336 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alvaro Pereira-Rico prescribed most often to Medicare patients was Abiraterone Acetate, with 383 prescriptions and refills. In total Alvaro Pereira-Rico wrote 1,660 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 383 | 383 | 53 | $907K |
| Prednisone Generic | 379 | 387 | 56 | $1,256 |
| Nubeqa Darolutamide | 154 | 154 | 21 | $2.0M |
| Tamsulosin Hcl Generic | 74 | 90 | 14 | $916 |
| Xtandi Enzalutamide | 52 | 52 | Under 11 | $691K |
| Bicalutamide Generic | 49 | 55 | Under 11 | $1,104 |
| Oxycodone Hcl Generic | 46 | 47 | 11 | $604 |
| Nilutamide Generic | 45 | 45 | Under 11 | $171K |
| Ondansetron Hcl Generic | 44 | 44 | 16 | $1,819 |
| Medroxyprogesterone Acetate Generic | 40 | 45 | 12 | $333 |
| Olanzapine Generic | 39 | 39 | 17 | $365 |
| Dexamethasone Generic | 38 | 40 | Under 11 | $351 |
| Orgovyx Relugolix | 31 | 31 | Under 11 | $82K |
| Hydrocortisone Generic | 23 | 23 | Under 11 | $718 |
| Levothyroxine Sodium Generic | 19 | 29 | Under 11 | $101 |
Brand drugs: 310 claims; generic drugs: 1,350 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alvaro Pereira-Rico $190 ($190 in general payments such as food, travel and fees) from 2 companies. The largest payer was Caris MPI, Inc. with $146.
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 2 | $146 |
| Daiichi Sankyo Inc. 4568.T | 2 | $43.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.